Foods and beverages, including bakery, nutrition bar, and cereal and pasta products, can now use the claim.
Ingredion Inc.’s (Westchester, IL) Hi-Maize high-amylose maize resistant starch has a newly approved qualified health claim from FDA linking the ingredient with a reduction in the risk of type 2 diabetes.
Foods and beverages-including bakery, nutrition bar, and cereal and pasta products-using Hi-Maize can now use the claims:
According to Ingredion, FDA based its assessment on eight clinical trials showing the positive impact of Hi-Maize on insulin sensitivity and other biomarkers related to blood sugar.
“We believe the new qualified health claim is a positive development for consumers as it provides another pragmatic approach to potential diabetes risk reduction through everyday foods,” said Lorraine Niba, PhD, global director, nutrition springboard, for Ingredion.
Nutritional Outlook magazine